BIO logo

BIO

Bio-Rad Laboratories Inc. Class A

$316.70
+$13.09(+4.31%)
52
Overall
50
Value
54
Tech
--
Quality
Market Cap
$8.30B
Volume
126.65K
52W Range
$211.43 - $373.69
Target Price
$341.25

Latest News for BIO

Sabio Holdings to Release Q3 2025 Financial Results
TipRanks Canadian Auto-Generated Newsdeska day agoNov 22, 2025

The latest announcement is out from Sabio Holdings ( ($TSE:SBIO) ). Sabio Holdings announced it will release its unaudited fiscal Q3 2025 financial......

Zenas BioPharma Reports Q3 2025 Financial Results
TipRanks Auto-Generated Newsdesk8 days agoNov 15, 2025

Zenas BioPharma, Inc. ( ($ZBIO) ) has released its Q3 earnings. Here is a breakdown of the information Zenas BioPharma, Inc. presented to its inves......

Jade Biosciences Advances Autoimmune Therapies
TipRanks Auto-Generated Newsdesk8 days agoNov 15, 2025

Jade Biosciences, Inc. ( ($JBIO) ) has released its Q3 earnings. Here is a breakdown of the information Jade Biosciences, Inc. presented to its inv......

Fortress Biotech’s Earnings Call Highlights EMROSI Success
TipRanks Auto-Generated Newsdesk8 days agoNov 15, 2025

Fortress Biotech Inc (($FBIO)) has held its Q3 earnings call. Read on for the main highlights of the call. Fortress Biotech Inc’s recent earnings c......

BioVaxys Announces Debt Settlement to Strengthen Financial Position
TipRanks Canadian Auto-Generated Newsdesk9 days agoNov 14, 2025

The latest update is out from BioVaxys Technology ( ($TSE:BIOV) ). BioVaxys Technology Corp. has announced a debt settlement transaction with certa......

Bioceres Crop Solutions (BIOX) Receives a Hold from Canaccord Genuity
TipRanks Auto-Generated Intelligence Newsdesk9 days agoNov 14, 2025

In a report released today, Austin Moeller from Canaccord Genuity maintained a Hold rating on Bioceres Crop Solutions, with a price target of $2.25......

MindBio Therapeutics Reports Phase 2B Trial Results on Microdosed LSD for Depression
TipRanks Canadian Auto-Generated Newsdesk10 days agoNov 13, 2025

The latest update is out from Mindbio Therapeutics Corp. ( ($TSE:MBIO) ). MindBio Therapeutics Corp. announced the results of its Phase 2B clinical......

iBio, Inc. Reports Q3 2025 Financial Results
TipRanks Auto-Generated Newsdesk10 days agoNov 13, 2025

Ibio Inc ( ($IBIO) ) has released its Q1 earnings. Here is a breakdown of the information Ibio Inc presented to its investors. iBio, Inc. is a prec......

Bioceres Crop Solutions Faces Legal Action Over Alleged Defaults
TipRanks Auto-Generated Newsdesk11 days agoNov 12, 2025

An announcement from Bioceres Crop Solutions ( ($BIOX) ) is now available. On November 10, 2025, Bioceres Crop Solutions received an Acceleration N......

BioVaxys Extends Private Placement to Boost Immunotherapy Pipeline
TipRanks Canadian Auto-Generated Newsdesk11 days agoNov 12, 2025

The latest announcement is out from BioVaxys Technology ( ($TSE:BIOV) ). BioVaxys Technology Corp. announced an extension of its non-brokered priva......

News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 28 articles.

ABCD
1SymbolPriceChangeVol
2BIO$316.70+4.3%126.65K
3
4
5
6

Get Bio-Rad Laboratories Inc. Class A Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.